Osteoporosis is a significant issue for many adults as it can take away independence and mobility. According to research, for every five adults who suffer a hip fracture, two will succumb to injury complications within a year. That is why we examine HGH therapy for bone density and osteoporosis. In this report, we look at how growth hormone influences bone cell growth and fracture healing.
Some controversy exists over the use of HGH treatment for osteoporosis. There is limited long-term research available. In one report, human growth hormone used in men diagnosed with idiopathic osteoporosis (both continuously and intermittently with calcium and vitamin D3) for two years resulted in the following:
- Increased bone mineral density (BMD) in the lumbar spine and total body
- An increase in total body bone mineral content (BMC)
The BMC increase was sustained for at least one year following the end of treatment.
Human Growth Hormone replacement helps to produce osteoblasts and osteoclasts to maintain strong bones.
How HGH Works for Bones in Adults
The role of growth hormone on bone development and bone density is as follows:
- Growth hormone, along with insulin growth factor 1 (its mediating hormone), stimulates the production of new bone cells (osteoblasts). These osteoblasts are necessary for maintaining bone structure as old bone cells are absorbed.
- GH and IGF-1 also stimulate osteoclast differentiation and activity, which is crucial for bone resorption. Osteoclasts dissolve the old bone cells so that the new osteoblasts can fill in and strengthen the bones.
How HGH Affects Osteoporosis Fractures
The bone cell cycle of life is roughly ten years. If bone cells die off and not enough new ones are available to take their place, osteoporosis can occur. Bone remodeling is ongoing – 10% of all bone cells are constantly in this stage. It takes about 30 to 40 days for resorption of a bone cell following its death. The formation of the new bone cell takes about 150 days. These new bone cells must be available to fill the resorption lacuna to prevent bone loss and weakening.
Without the filling of the resorption lacuna, the bones become brittle and subject to osteoporotic fracture. The use of HGH therapy for bone density enhancement can help ensure a constant supply of osteoblasts ready to fill in the gap.
A ten-year study showed that women who received HGH therapy had a 50% decline in fractures during that time compared to a four-fold increase in fractures of women in the control group. A picture of Osteoporosis stages below.
Growth Hormone and Fracture Healing
Because HGH increases the proliferation of osteoblasts, its use may be able to heal bones faster following a fracture. The use of HGH therapy for bone density and fracture healing requires additional research.
In one study of HGH use for bone repair, tibial fractures following surgery healed in 95 days compared to 129 for the placebo group. Other small studies have produced positive results, but significantly more research is necessary before using HGH for healing of fractures.
Reviews of Our Patients with Osteoporosis on HGH Therapy and Bones Density
When I was diagnosed with osteoporosis, I got scared. I heard about HGH benefiting bone density, so I decided to learn more. After finding out I had low growth hormone levels, I started treatment. That was slightly more than two years ago. Today, my bones are stronger, and I have fewer joint pains. HGH has helped reduced my risk of fractures.
With HGH therapy, I no longer suffer from debilitating joint pains. I had no idea that my pain was due to reduced bone density. Growth hormone deficiency created many problems for me, including osteoporosis risk. I no longer have those worries. I look forward to my continued results.
After being diagnosed with osteopenia, I researched different treatment options. That is how I found out about HGH therapy. I also had other symptoms of growth hormone deficiency. I have used HGH for two years, and my doctor told me that I no longer have osteopenia. Now, I am no longer worried about developing osteoporosis.